Company Monitoring Page for JNJ

latest headlines for company on cafepharma

J&J sues Amgen over plan to sell drug similar to Stelara
Business Insurance
Thu, 12/1/22 - 10:48 am
Tags:
JNJ, Janssen, Amgen, legal, ulcerative colitis, patents, Stelara
J&J unit, happy with AC Immune Alzheimer's work, moves 1 of 2 shots to next step
Fierce Biotech
Thu, 12/1/22 - 10:33 am
Tags:
JNJ, AC Immune, Alzheimer's disease, Janssen, vaccines, ACI-35.030
Large pharmas probe takeover of Horizon Therapeutics
BioPharma Dive
Wed, 11/30/22 - 10:58 am
Tags:
Horizon Pharma, M&A, JNJ, Sanofi, Amgen
J&J Vision Sets Sights on Sustainability
Medical Devices and Diagnostics Industry
Wed, 11/30/22 - 10:39 am
Tags:
JNJ, Medtech, JNJ Vision, sustainability
Janssen’s Phase IIIb major depressive disorder trial meets primary endpoint
Clinical Trials Arena
Sat, 11/26/22 - 07:17 pm
Tags:
Janssen, JNJ, clinical trials, Spravato, treatment-resistant depression
GSK, J&J and AZ top global drug access index, but foundation says plenty more work needs to be done
Fierce Pharma
Thu, 11/17/22 - 12:13 pm
Tags:
GSK, JNJ, AstraZeneca, Access to Medicine Foundation, drug access
Pfizer musters J&J, PhRMA's support in closely watched Vyndaqel copay assistance case at Supreme Court
Fierce Pharma
Tue, 11/15/22 - 10:32 am
Tags:
Pfizer, JNJ, copay asssistance programs, kickbacks, Vyndaqel, Vyndamax, Supreme Court
Johnson & Johnson Could Level Up With Its $16.8 Billion Purchase of Abiomed
Motley Fool
Thu, 11/10/22 - 10:33 am
Tags:
JNJ, Medtech, devices, Abiomed, M&A
J&J vet Mammen wanted board influence to be Biogen's next CEO, but chairman said no
Fierce Pharma
Tue, 11/8/22 - 10:43 pm
Tags:
JNJ, Biogen, Pharma CEOs, Mathai Mammen
J&J, Idorsia plan filings for aprocitentan data in resistant hypertension
Pharmaphorum
Tue, 11/8/22 - 10:33 pm
Tags:
JNJ, Idorsia, aprocitentan, hypertension, resistant hypertension
Ash 2022 preview – a new multiple myeloma mechanism makes a splash
EP Vantage
Sun, 11/6/22 - 01:23 pm
Tags:
ASH 2022, JNJ, talquetamab, mutliple myeloma
Johnson & Johnson to Buy Abiomed for $16.6B
Medical Devices and Diagnostics Industry
Tue, 11/1/22 - 11:08 am
Tags:
JNJ, devices, Medtech, Abiomed, M&A
Janssen Steps Away from Phase I Prostate Cancer Study, Cites Patient Enrollment Issues
BioSpace
Mon, 10/31/22 - 04:14 pm
Tags:
Essa Pharma, Janssen, JNJ, prostate cancer, clinical trials, EPI-7386
J&J nabs FDA okay for BCMA bispecific Tecvayli
Pharmaphorum
Wed, 10/26/22 - 07:00 pm
Tags:
JNJ, Multiple Myeloma, Tecvayli, FDA
New TREMFYA Data Show an Overall Clinical Response Rate of Approximately 80 Percent in a Phase 2b Induction Study of Adults with Moderately to Severely Active Ulcerative Colitis
Marketscreener
Tue, 10/25/22 - 10:53 am
Tags:
JNJ, Janssen, clinical trials, ulcerative colitis, Tremfya
Boston Scientific, Edwards set to report Q3 results after ‘encouraging start’ to medtech earnings season
Medtech Dive
Tue, 10/25/22 - 10:46 am
Tags:
earnings, Medtech, devices, Boston Scientific, JNJ, Edwards Lifesciences
Pfizer, Merck and J&J Back UK Startup Mining the Dark Genome for Autoimmune Therapies
BioSpace
Wed, 10/19/22 - 10:44 am
Tags:
Nucleome Therapeutics, funding, precision medicine, autoimmune diseases, Pfizer, JNJ, Merck KGaA, autoimmune disease
J&J’s $5bn projects have much to prove
EP Vantage
Wed, 10/19/22 - 10:37 am
Tags:
JNJ, milvexian, nipocalimab, Carvykti, Rybrevant/lazertinib
J&J holds off on volatile M&A market but has plenty of cash for a deal
Endpoints
Tue, 10/18/22 - 10:02 pm
Tags:
JNJ, M&A
COVID vaccine boosts J&J pharma sales in Q3
Medical Marketing and Media
Tue, 10/18/22 - 10:53 am
Tags:
JNJ, COVID-19, vaccines, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.